Last10K.com

Mckesson Corp (MCK) SEC Filing 10-Q Quarterly Report for the period ending Thursday, September 30, 2021

Mckesson Corp

CIK: 927653 Ticker: MCK

Exhibit 99.1


mckessonlogoa03a.jpg

McKESSON REPORTS FISCAL 2022 SECOND-QUARTER RESULTS

Second-Quarter Highlights, Year-over-Year:
Total revenues of $66.6 billion increased 9%
Earnings per diluted share from continuing operations of $1.71 decreased $1.83
Adjusted Earnings per Diluted Share of $6.15 increased 28%

Fiscal 2022 Outlook:
Increased fiscal 2022 Adjusted Earnings per Diluted Share guidance range to $21.95 to $22.55, from the previous range of $19.80 to $20.40, representing 27.5% to 31% growth compared to prior year.
Fiscal 2022 Adjusted Earnings per Diluted Share guidance includes approximately $2.30 to $3.05 of impacts attributable to the following:
$1.30 to $1.80 related to the U.S. government’s COVID-19 vaccine distribution, kitting, and storage programs
$0.50 to $0.75 related to COVID-19 tests and impairments for personal protective equipment and related products
$0.49 related to year-to-date gains or losses associated with McKesson Ventures’ equity investments
Excluding the impacts of the above items from both fiscal 2022 guidance and fiscal 2021 results, indicates 20% to 29% forecasted growth.

IRVING, Texas, November 1, 2021 -
McKesson Corporation (NYSE:MCK) today reported strong second-quarter results for the period ended September 30, 2021.
Fiscal 2022 Second-Quarter Result Summary
Second-Quarter
Year-to-Date
($ in millions, except per share amounts)FY22FY21ChangeFY22FY21Change
Revenues$66,576 $60,808 %$129,250 $116,487 11 %
Income from Continuing Operations 1
267 577 (54)756 1,022 (26)
Adjusted Earnings 1,2
958 784 22 1,838 1,237 49 
Earnings per Diluted Share 1
1.71 3.54 (52)4.82 6.26 (23)
Adjusted Earnings per Diluted Share 1,2
6.15 4.80 28 11.71 7.58 54 
1 Reflects continuing operations attributable to McKesson, net of tax
2 Represents a non-GAAP financial measure; refer to the reconciliations of non-GAAP financial measures included in accompanying schedules
"Our enterprise strategy is enabling us to successfully navigate a dynamic environment. McKesson delivered strong second-quarter results, including double-digit Adjusted Operating Profit growth across all segments," said Brian Tyler, chief executive officer. "We remain committed to investing in our growth strategies of biopharma services and oncology ecosystems, while simultaneously increasing shareholder returns.”


The following information was filed by Mckesson Corp (MCK) on Monday, November 1, 2021 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Mckesson Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Mckesson Corp.

Continue

Assess how Mckesson Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Mckesson Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
Legal
Other
Filter Subcategory:
All
Expense
Shares
Cash Flow
Earnings
Product
Income
Debt
Geography
Other
Inside Mckesson Corp's 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Comprehensive Income
Condensed Consolidated Statements Of Operations
Condensed Consolidated Statements Of Stockholders' Equity (Deficit)
Condensed Consolidated Statements Of Stockholders' Equity (Deficit) (Parenthetical)
Commitments And Contingent Liabilities
Commitments And Contingent Liabilities (Tables)
Commitments And Contingent Liabilities - Estimated Accrual Liability (Details)
Commitments And Contingent Liabilities - Narrative (Details)
Debt And Financing Activities
Debt And Financing Activities (Tables)
Debt And Financing Activities - Commercial Paper (Details)
Debt And Financing Activities - Long-Term Debt Narrative (Details)
Debt And Financing Activities - Revolving Credit Facilities (Details)
Debt And Financing Activities - Schedule Of Long-Term Debt (Details)
Earnings (Loss) Per Common Share
Earnings (Loss) Per Common Share (Details)
Earnings (Loss) Per Common Share (Tables)
Fair Value Measurements
Fair Value Measurements (Tables)
Fair Value Measurements - Narrative (Details)
Fair Value Measurements - Schedule Of Long-Term Debt Is Recorded At Amortized Cost (Details)
Goodwill And Intangible Assets, Net
Goodwill And Intangible Assets, Net (Tables)
Goodwill And Intangible Assets, Net - Narrative - Intangible Assets (Details)
Goodwill And Intangible Assets, Net - Schedule Of Changes In The Carrying Amount Of Goodwill (Details)
Goodwill And Intangible Assets, Net - Schedule Of Information Regarding Intangible Assets (Details)
Hedging Activities
Hedging Activities (Tables)
Hedging Activities - Derivative Instruments Fair Value (Details)
Hedging Activities - Narrative (Details)
Held For Sale
Held For Sale (Tables)
Held For Sale - Assets And Liabilities Held For Sale (Details)
Held For Sale - Narrative (Details)
Income Taxes
Income Taxes (Details)
Pension Benefits
Pension Benefits - Narrative (Details)
Redeemable Noncontrolling Interests And Noncontrolling Interests
Redeemable Noncontrolling Interests And Noncontrolling Interests (Tables)
Redeemable Noncontrolling Interests And Noncontrolling Interests - Narrative (Details)
Redeemable Noncontrolling Interests And Noncontrolling Interests - Schedule Of Changes In Redeemable Noncontrolling Interests And Noncontrolling Interests (Details)
Restructuring, Impairment, And Related Charges
Restructuring, Impairment, And Related Charges (Tables)
Restructuring, Impairment, And Related Charges - Narrative (Details)
Restructuring, Impairment, And Related Charges - Summary Of Restructuring Activity (Details)
Restructuring, Impairment, And Related Charges - Summary Of Restructuring Charges (Details)
Segments Of Business
Segments Of Business (Tables)
Segments Of Business - Narrative (Details)
Segments Of Business - Reportable Operating Segment (Details)
Significant Accounting Policies
Significant Accounting Policies (Policies)
Significant Accounting Policies - Narrative (Details)
Stockholders' Equity (Deficit)
Stockholders' Equity (Deficit) (Tables)
Stockholders' Equity (Deficit) - Narrative (Details)
Stockholders' Equity (Deficit) - Schedule Of Changes In Accumulated Other Comprehensive Income (Loss) By Component (Details)

Material Contracts, Statements, Certifications & more

Mckesson Corp provided additional information to their SEC Filing as exhibits

Ticker: MCK
CIK: 927653
Form Type: 10-Q Quarterly Report
Accession Number: 0000927653-21-000098
Submitted to the SEC: Mon Nov 01 2021 5:41:12 PM EST
Accepted by the SEC: Tue Nov 02 2021
Period: Thursday, September 30, 2021
Industry: Wholesale Drugs Proprietaries And Druggists Sundries

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/mck/0000927653-21-000098.htm